These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 572929)

  • 1. Results of the national surveillance for Guillain-Barré syndrome.
    Nelson DB; Holman R; Hurwitz E; Schonberger LB; Bregman DJ; Kaslow RA
    Neurology; 1979 Jul; 29(7):1029-32. PubMed ID: 572929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National surveillance for Guillain-Barré syndrome: January 1978-March 1979.
    Hurwitz ES; Holman RC; Nelson DB; Schonberger LB
    Neurology; 1983 Feb; 33(2):150-7. PubMed ID: 6681655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance.
    Prevots DR; Sutter RW
    J Infect Dis; 1997 Feb; 175 Suppl 1():S151-5. PubMed ID: 9203708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome: its epidemiology and associations with influenza vaccination.
    Schonberger LB; Hurwitz ES; Katona P; Holman RC; Bregman DJ
    Ann Neurol; 1981; 9 Suppl():31-8. PubMed ID: 7224614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome and the 1978-1979 influenza vaccine.
    Hurwitz ES; Schonberger LB; Nelson DB; Holman RC
    N Engl J Med; 1981 Jun; 304(26):1557-61. PubMed ID: 7231501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America.
    Olivé JM; Castillo C; Castro RG; de Quadros CA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S160-4. PubMed ID: 9203710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.
    Schonberger LB; Bregman DJ; Sullivan-Bolyai JZ; Keenlyside RA; Ziegler DW; Retailliau HF; Eddins DL; Bryan JA
    Am J Epidemiol; 1979 Aug; 110(2):105-23. PubMed ID: 463869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system.
    Kaplan JE; Schonberger LB; Hurwitz ES; Katona P
    Neurology; 1983 May; 33(5):633-7. PubMed ID: 6682501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, Western Norway.
    Larsen JP; Kvåle G; Nyland H
    Acta Neurol Scand; 1985 Jan; 71(1):43-7. PubMed ID: 3872003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Guillain-Barré syndrome.
    Schoenberg BS
    Adv Neurol; 1978; 19():249-60. PubMed ID: 369322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group.
    Safranek TJ; Lawrence DN; Kurland LT; Culver DH; Wiederholt WC; Hayner NS; Osterholm MT; O'Brien P; Hughes JM
    Am J Epidemiol; 1991 May; 133(9):940-51. PubMed ID: 1851395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines.
    Langmuir AD; Bregman DJ; Kurland LT; Nathanson N; Victor M
    Am J Epidemiol; 1984 Jun; 119(6):841-79. PubMed ID: 6328974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977.
    Breman JG; Hayner NS
    Am J Epidemiol; 1984 Jun; 119(6):880-9. PubMed ID: 6731430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and epidemiologic features of Guillain-Barré syndrome.
    Hughes RA; Rees JH
    J Infect Dis; 1997 Dec; 176 Suppl 2():S92-8. PubMed ID: 9396689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93.
    Jiang GX; Cheng Q; Link H; de Pedro-Cuesta J
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):447-53. PubMed ID: 9153599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
    Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
    N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome in Stockholm County, 1973-1991.
    Jiang GX; Cheng Q; Ehrnst A; Link H; de Pedro-Cuesta J
    Eur J Epidemiol; 1997 Jan; 13(1):25-32. PubMed ID: 9062775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.
    Tuttle J; Chen RT; Rantala H; Cherry JD; Rhodes PH; Hadler S
    Am J Public Health; 1997 Dec; 87(12):2045-8. PubMed ID: 9431302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barre syndrome. Another immune-mediated disease with a predilection for young women?
    Riggs JE; Gutmann L; Whited JD
    W V Med J; 1989 Sep; 85(9):382-3. PubMed ID: 2789453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.